|
Dr. Fort enjoyed 26 years in pharmaceutical industry R&D first at ER Squibb & Sons New Brunswick NJ then Abbott Laboratories North Chicago IL and TAP Pharmaceuticals Lake Forest IL with 1 year at Takeda Chemical Ind. Ltd. Osaka Japan before joining Cleveland BioLabs on July 1 2005. He developed expertise in pre-clinical safety assessment with continually increasing responsibilities. At TAP he was Director of Drug Safety. He holds a Ph.D. in Biochemistry & Molecular Biology from the University of Florida an MBA from the Lake Forest Graduate School of Management and is certified in toxicology by the American Board of Toxicology. Throughout his career and particularly at TAP he gained exposure to all phases of drug development and contributed to several successful FDA New Drug Applications (NDA) for marketing approval. At Cleveland BioLabs Dr. Fort is responsible for all drug development activities including manufacturing active pharmaceutical ingredient and drug product pre-clinical safety assessment regulatory affairs and clinical development. | 